#None #Rome #biomedical innovation #Haier Biomedical #European Summit

Haier Biomedical's European Partner Summit: A Leap Towards Local Innovation

Haier Biomedical gathered key industry leaders and partners from 23 European countries at its recent European Partner Summit held in Rome. The event, themed "Advancing Together — Sharing the Future of Biomedical Innovation," marked a pivotal moment for the company in reasserting its commitment to the European market and unveiling an enhanced portfolio of laboratory solutions, a significant step in the brand's strategic renewal.

Embracing a Future-Focused Strategy

The summit highlighted Haier Biomedical’s long-term vision, with Enrique Wang, the company’s Global Market Director, stating the aim for over 50% of total revenue to come from international markets by 2027. He emphasized that Europe remains a strategic priority, with the principle of "In Europe, for Europe" guiding the development of products tailored to regional regulations, customer expectations, and application specifics.

Simir Selimovic, Director for Northern, Central, and Eastern Europe, underlined the importance of investing in local sales, service teams, and product expertise to enhance responsiveness in key markets. Haier Biomedical has identified Europe as one of its fastest-growing regions, facilitated by strengthening local teams and continuously expanding its product range.

Innovative Solutions for the Biomedical Sector

Among the innovative solutions showcased was the Plasma Apheresis XJ-III system, which is certified under the EU's MDR regulations. This achievement signifies a major milestone in ensuring compliance with stringent European standards, positioning Haier Biomedical solidly in the blood and plasma processing technology sector. The brand’s presence in Europe continues to grow through its energy-efficient technologies and adherence to regional certification standards.

The product evolution unveiled in Rome reflects Haier Biomedical's transition towards offering a comprehensive array of solutions to support laboratories, hospitals, and biomedical institutions. Daniele Pericolini, an automation expert at Haier Biomedical, outlined the company’s strategy to drive future growth through laboratory automation and intelligent blood management systems. Their automated solutions for biobanks meld ultra-low temperature storage with RFID support, modular automation platforms, and liquid nitrogen systems to enhance sample traceability and operational efficiency.

Furthermore, U-Blood, the intelligent blood management system, represents a shift from traditional cold storage to real-time blood supply chain management, addressing challenges like sample integrity and temperature control while aligning with European safety and healthcare digitalization initiatives.

Success Stories and Market Recognition

The summit also featured success stories from four European partners in Germany, Slovenia, France, and Denmark, illustrating Haier Biomedical's strong recognition in local markets. In France, a long-standing partner showcased a bespoke safety cabinet developed to meet French standards, with over 230 units installed across more than 100 clients. Meanwhile, the Danish partner shared its success in promoting ultra-low-temperature freezers through public tenders and continuous expansion into new product categories. Slovenian pharmaceutical projects reaffirmed the company’s capability in handling complex multi-component configurations. Central European partners highlighted reliability, regulatory compliance, and exceptional after-sales support as key competitive advantages.

Sustained Financial Growth and Market Expansion

Haier Biomedical's expansion in Europe is bolstered by robust financial results, with 2025 revenues surpassing 2.3 billion yuan. International revenue reached 840 million yuan, accounting for over 36% of total revenue, reflecting continued global expansion. The European market displayed double-digit growth, contributing significantly to overall international sales. AI and automation-related solutions generated about 15% of total revenue, underscoring the acceleration of technological transformation within the business. These outcomes illustrate a broader shift from equipment exports to delivering localized solutions, supported by regional teams and certifications across more than 18 countries.

As the European Partner Summit concluded, Haier Biomedical reaffirmed its commitment to developing localized operations, expanding automation solutions and biomedical sciences, and fostering collaboration with partners. By combining global innovative capabilities with localized implementations in Europe, the company aims to strengthen its position as a trusted provider of biomedical solutions in 2026 and beyond.

For more information, visit Haier Biomedical's website.

Watch the summit video